317 related articles for article (PubMed ID: 35483239)
21. Foveal changes in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder are independent of optic neuritis and not overtly progressive.
Roca-Fernández A; Oertel FC; Yeo T; Motamedi S; Probert F; Craner MJ; Sastre-Garriga J; Zimmermann HG; Asseyer S; Kuchling J; Bellmann-Strobl J; Ruprecht K; Leite MI; Paul F; Brandt AU; Palace J
Eur J Neurol; 2021 Jul; 28(7):2280-2293. PubMed ID: 33547839
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children.
Hacohen Y; Mankad K; Chong WK; Barkhof F; Vincent A; Lim M; Wassmer E; Ciccarelli O; Hemingway C
Neurology; 2017 Jul; 89(3):269-278. PubMed ID: 28615429
[TBL] [Abstract][Full Text] [Related]
23. MRI characteristics of MOG-Ab associated disease in adults: An update.
Shor N; Deschamps R; Cobo Calvo A; Maillart E; Zephir H; Ciron J; Papeix C; Durand-Dubief F; Ruet A; Ayrignac X; Cohen M; Deiva K; Laplaud D; Bourre B; Audoin B; Collongues N; Vukusic S; Cotton F; Marignier R;
Rev Neurol (Paris); 2021; 177(1-2):39-50. PubMed ID: 33046261
[TBL] [Abstract][Full Text] [Related]
24. What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM).
Carnero Contentti E; Lopez PA; Pettinicchi JP; Pappolla A; Miguez J; Patrucco L; Cristiano E; Vrech C; Tkachuk V; Liwacki S; Correale J; Marrodan M; Gaitán MI; Fiol M; Negrotto L; Ysrraelit MC; Burgos M; Leguizamon F; Tavolini D; Deri N; Balbuena ME; Mainella C; Luetic G; Blaya P; Hryb J; Menichini ML; Alvez Pinheiro A; Nofal P; Zanga G; Barboza A; Martos I; Lazaro L; Alonso R; Silva E; Bestoso S; Fracaro ME; Carrá A; Garcea O; Fernandez Liguori N; Alonso Serena M; Caride A; Rojas JI
Mult Scler Relat Disord; 2021 Apr; 49():102742. PubMed ID: 33454601
[TBL] [Abstract][Full Text] [Related]
25. Comparison of MRI T2-lesion evolution in pediatric MOGAD, NMOSD, and MS.
Redenbaugh V; Chia NH; Cacciaguerra L; McCombe JA; Tillema JM; Chen JJ; Lopez Chiriboga AS; Sechi E; Hacohen Y; Pittock SJ; Flanagan EP
Mult Scler; 2023 Jun; 29(7):799-808. PubMed ID: 37218499
[TBL] [Abstract][Full Text] [Related]
26. The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis.
Messina S; Mariano R; Geraldes R; Kim SH; Satukijcha C; Vecchio D; Chua YY; Taylor J; George N; Cavey A; Diaz AR; Reeve S; Everett R; De Luca G; Leite MI; Kim HJ; Palace J
Mult Scler Relat Disord; 2021 Apr; 49():102773. PubMed ID: 33540279
[TBL] [Abstract][Full Text] [Related]
27. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
Fan S; Xu Y; Ren H; Guan H; Feng F; Gao X; Ding D; Fang F; Shan G; Guan T; Zhang Y; Dai Y; Yao M; Peng B; Zhu Y; Cui L
Mult Scler Relat Disord; 2018 Feb; 20():144-152. PubMed ID: 29414288
[TBL] [Abstract][Full Text] [Related]
28. Subclinical retinal atrophy in the unaffected fellow eyes of multiple sclerosis and neuromyelitis optica.
Akaishi T; Kaneko K; Himori N; Takeshita T; Takahashi T; Nakazawa T; Aoki M; Nakashima I
J Neuroimmunol; 2017 Dec; 313():10-15. PubMed ID: 29153600
[TBL] [Abstract][Full Text] [Related]
29. Differentiated pattern of complement system activation between MOG-IgG-associated disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder.
Cho EB; Min JH; Waters P; Jeon M; Ju ES; Kim HJ; Kim SH; Shin HY; Kang SY; Lim YM; Oh SY; Lee HL; Sohn E; Lee SS; Oh J; Kim S; Huh SY; Cho JY; Seok JM; Kim BJ; Kim BJ
Front Immunol; 2024; 15():1320094. PubMed ID: 38576611
[TBL] [Abstract][Full Text] [Related]
30. Unfavorable Structural and Functional Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis.
Jelcic I; Hanson JVM; Lukas S; Weber KP; Landau K; Pless M; Reindl M; Weller M; Martin R; Lutterotti A; Schippling S
J Neuroophthalmol; 2019 Mar; 39(1):3-7. PubMed ID: 30015656
[TBL] [Abstract][Full Text] [Related]
31. Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients.
Narayan RN; McCreary M; Conger D; Wang C; Greenberg BM
Mult Scler Relat Disord; 2019 Feb; 28():86-90. PubMed ID: 30576847
[TBL] [Abstract][Full Text] [Related]
32. The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients.
Siritho S; Sato DK; Kaneko K; Fujihara K; Prayoonwiwat N
Mult Scler; 2016 Jun; 22(7):964-8. PubMed ID: 26498263
[TBL] [Abstract][Full Text] [Related]
33. Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.
Piccolo L; Woodhall M; Tackley G; Juryńczyk M; Kong Y; Domingos J; Gore R; Vincent A; Waters P; Leite MI; Palace J
J Neurol; 2016 Feb; 263(2):370-379. PubMed ID: 26668077
[TBL] [Abstract][Full Text] [Related]
34. Structural and visual functional deficits in a rat model of neuromyelitis optica spectrum disorders related optic neuritis.
Zhang Y; Bao Y; Qiu W; Peng L; Fang L; Xu Y; Yang H
Exp Eye Res; 2018 Oct; 175():124-132. PubMed ID: 29913164
[TBL] [Abstract][Full Text] [Related]
35. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
[TBL] [Abstract][Full Text] [Related]
36. Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topics.
Fujihara K; Cook LJ
Curr Opin Neurol; 2020 Jun; 33(3):300-308. PubMed ID: 32374571
[TBL] [Abstract][Full Text] [Related]
37. MRI findings in pediatric neuromyelitis optica spectrum disorder with MOG antibody: Four cases and review of the literature.
Ikeda A; Watanabe Y; Kaba H; Kaneko K; Takahashi T; Takeshita S
Brain Dev; 2019 Apr; 41(4):367-372. PubMed ID: 30447856
[TBL] [Abstract][Full Text] [Related]
38. Clinical Characteristics of Pediatric Optic Neuritis With Myelin Oligodendrocyte Glycoprotein Seropositive: A Cohort Study.
Chen Q; Zhao G; Huang Y; Li Z; Sun X; Lu P; San Y; Wang M; Tian G
Pediatr Neurol; 2018 Jun; 83():42-49. PubMed ID: 29778487
[TBL] [Abstract][Full Text] [Related]
39. Retinal Changes in Double-Antibody Seronegative Neuromyelitis Optica Spectrum Disorders.
Oertel FC; Zimmermann HG; Motamedi S; Bereuter C; Manthey LM; Ashtari F; Kafieh R; Dehghani A; Pourazizi M; Pandit L; D'Cunha A; Aktas O; Albrecht P; Ringelstein M; Martinez-Lapiscina EH; Sanchez Dalmau BF; Villoslada P; Asgari N; Marignier R; Cobo-Calvo A; Leocani L; Pisa M; Radaelli M; Palace J; Roca-Fernandez A; Leite MIS; Sharma S; De Seze J; Senger T; Yeaman MR; Smith TJ; Cook LJ; Brandt AU; Paul F;
Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200273. PubMed ID: 38941573
[TBL] [Abstract][Full Text] [Related]
40. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis.
Ramanathan S; Prelog K; Barnes EH; Tantsis EM; Reddel SW; Henderson AP; Vucic S; Gorman MP; Benson LA; Alper G; Riney CJ; Barnett M; Parratt JD; Hardy TA; Leventer RJ; Merheb V; Nosadini M; Fung VS; Brilot F; Dale RC
Mult Scler; 2016 Apr; 22(4):470-82. PubMed ID: 26163068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
